Citation Impact
Citing Papers
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
Systematic Review of Patients Presenting With Suspected Myocardial Infarction and Nonobstructive Coronary Arteries
2015
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin
2013
Coagulation induced by C3aR-dependent NETosis drives protumorigenic neutrophils during small intestinal tumorigenesis
2016
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta‐analysis
2013
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease
2006
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: The Randomized, phase II study to Evaluate the sAfety and pharmacokinetics of oraL dabIGatran etexilate in patients after heart valve replacemeNt (RE-ALIGN)
2012
Six-Month Echocardiographic Study in Patients With Submassive Pulmonary Embolism and Right Ventricle Dysfunction: Comparison of Thrombolysis With Heparin
2010
Intracerebral haemorrhage
2009 Standout
Evidence-Based Management of Anticoagulant Therapy
2012
Contribution of platelets to tumour metastasis
2011 Standout
Impact of the efficacy of thrombolytic therapy on the mortality of patients with acute submassive pulmonary embolism: a meta‐analysis
2014
Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis
2014
Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients
2009
Oral Anticoagulant Therapy
2012 Standout
Glioblastoma and Other Malignant Gliomas
2013 Standout
New Antithrombotic Drugs
2012
Antithrombotic Therapy for VTE Disease
2016 Standout
Thromboembolic disease in patients with high-grade glioma
2012
Treatment for superficial thrombophlebitis of the leg
2007
Utilisation and Safety of Bemiparin, a??Low-Molecular-Weight Heparin, in??Medical Patients
2005
Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
2013
Unresolved issues in anticoagulant therapy
2003
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysis
2010
Are temporary inferior vena cava filters really temporary?
2005
Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis
2013
Pulmonary embolism and deep vein thrombosis
2012
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Simplification of the Pulmonary Embolism Severity Index for Prognostication in Patients With Acute Symptomatic Pulmonary Embolism
2010
The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism
2010
Fondaparinux for Isolated Superficial Vein Thrombosis of the Legs
2011
Neutrophil extracellular traps in immunity and disease
2017 Standout
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Prevention of Venous Thromboembolism
2004 Standout
Meta-Analysis of Randomized Controlled Trials on the Risk of Bleeding With Dabigatran
2013
Clinical Characteristics, Management, and Outcomes of Patients Diagnosed With Acute Pulmonary Embolism in the Emergency Department
2011
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Thrombosis and cancer
2012
The Incidence of Recurrent Venous Thromboembolism After Treatment With Vitamin K Antagonists in Relation to Time Since First Event
2003
Vena Cava Filter Occlusion and Venous Thromboembolism Risk in Persistently Anticoagulated Patients
2009
Prevention of Venous Thromboembolism
2008 Standout
Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of ‘bridging’ antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel
2010
Retrievable Inferior Vena Cava filters are not getting retrieved
2010
Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism: a prospective, multicentre, cohort study with three months of follow-up
2009
Prospective validation of the Pulmonary Embolism Severity Index
2008
Catheter-directed interventions for acute pulmonary embolism
2014
Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage
2015
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
Thrombosis as an intravascular effector of innate immunity
2012 Standout
Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines
2012
Cancer-associated thrombosis: investigating the role of new oral anticoagulants
2015
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Treatment for superficial thrombophlebitis of the leg
2013
How I use fibrinogen replacement therapy in acquired bleeding
2014
Fibrinolysis for acute pulmonary embolism
2010
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
2002 Standout
Vena caval filters: a comprehensive review
2000
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
Management of Pulmonary Embolism with Rheolytic Thrombectomy
2011
Anticoagulation or Inferior Vena Cava Filter Placement for Patients With Primary Intracerebral Hemorrhage Developing Venous Thromboembolism?
2003
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Tinzaparin and enoxaparin given at prophylactic dose for eight days in medical elderly patients with impaired renal function
2007
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Systematic Review: d -Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism
2008
Superficial Venous Thrombosis and Venous Thromboembolism
2010
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
The Epidemiology of Venous Thromboembolism
2003 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
Fourth universal definition of myocardial infarction (2018)
2018 Standout
Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary Syndromes
2004
Axial and Reformatted Four-Chamber Right Ventricle–to–Left Ventricle Diameter Ratios on Pulmonary CT Angiography as Predictors of Death After Acute Pulmonary Embolism
2012
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
2013 Standout
Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review.
2005
Works of Patrick Mismetti being referenced
Superficial Venous Thrombosis and Venous Thromboembolism
2010
New oral antithrombotics: a need for laboratory monitoring. For
2010
A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancer
2006
Place des filtres caves dans le traitement de la maladie thromboembolique veineuse chez les patients cancéreux
2008
Evolution of blood coagulation and fibrinolysis parameters after abrupt versus gradual withdrawal of acenocoumarol in patients with venous thromboembolism: a double‐blind randomized study
1997
Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs
2010
Impact of double‐blind vs. open study design on the observed treatment effects of new oral anticoagulants in atrial fibrillation: a meta‐analysis
2013
Medical literature, vena cava filters and evidence of efficacy
2013
Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer
2012
Factors predictive of venous thrombotic complications in patients with isolated superficial vein thrombosis
2003
Short term effect of recombinant tissue plasminogen activator in patients with hemodynamically stable acute pulmonary embolism: Results of a meta-analysis involving 464 patients
2009
A Prospective Long-term Study of 220 Patients With a Retrievable Vena Cava Filter for Secondary Prevention of Venous Thromboembolism
2007
Some hemostasis variables at the end of the population distributions are risk factors for severe postpartum hemorrhages
2008
Symptomatic inferior vena cava filter thrombosis: clinical study of 30 consecutive cases
1996
Survival Effects of Inferior Vena Cava Filter in Patients With Acute Symptomatic Venous Thromboembolism and a Significant Bleeding Risk
2014
Long term prognosis of patients with myocardial infarction and normal coronary angiography: impact of inherited coagulation disorders
2003
A Randomized Trial of Dabigatran Versus Warfarin in the Treatment of Acute Venous Thromboembolism (RE-COVER II)
2011
An electronic tool for venous thromboembolism prevention in medical and surgical patients.
2006
Antiplatelet agents in the perioperative period: expert recommendations of the French Society of Anesthesiology and Intensive Care (SFAR) 2001--summary statement.
2003
The ultra-low molecular weight heparin (ULMWH) semuloparin for prevention of venous thromboembolism (VTE) in patients with cancer receiving chemotherapy: SAVE ONCO study.
2011
Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
2013
Clinical Predictors for Fatal Pulmonary Embolism in 15 520 Patients With Venous Thromboembolism
2008
Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment tool.
2003
Preventing Venous Thromboembolism in Medical Patients
2004
The Ultra-Low-Molecular-Weight Heparin Semuloparin for Prevention of Venous Thromboembolism In Patients Undergoing Major Abdominal Surgery
2010